Nanosized Trojan horses created from a patient’s own immune cells have successfully treated inflammation by overcoming the body’s complex defense mechanisms, perhaps leading to broader applications for treating diseases characterized by inflammation, such as cancer and cardiovascular diseases.
An international team, led by researchers at Houston Methodist Research Institute, described the creation of nanoparticles called leukosomes and evaluated their ability to treat localized inflammation in the May 23 issue of Nature Materials (early online).
Recent approaches to treating inflammatory diseases have been unsuccessful because an already overactive immune system treats simple nanoparticles as foreign invaders and clears them from the body, preventing them from reaching their target.
“A better approach for building effective drug delivery platforms is to find inspiration for their design in the composition of the immune cells of our body,” said Ennio Tasciotti, Ph.D., director of the Center for Biomimetic Medicine at Houston Methodist Research Institute and the paper’s senior author. “Immune cells such as leukocytes freely circulate in blood vessels, recognize inflammation, and accumulate in inflamed tissues. They do so by using special receptors and ligands on their surface. We purified leukocytes from a patient, then integrated their special ligands and receptors into the leukosome surface. Using the body’s own materials, we built a drug delivery system camouflaged as our own body’s defense system—thus the Trojan horse.”
In its normal form, acute inflammation is a necessary and beneficial part of the body’s defense against infection. However, under certain conditions, inflammation can turn from a friend to a vicious foe, damaging or destroying healthy cells. This is the case for autoimmune disorders such as rheumatoid arthritis, lupus and inflammatory bowel disease, or in illnesses such as Alzheimer’s, cancer, cardiovascular disease and Type 2 diabetes.
Leukosomes are able to target inflamed tissues because they retain the same surface properties of the immune cell membranes from which they are made. To evaluate leukosomes’ effectiveness as drug carriers, Tasciotti and his colleagues created vesicles from mouse leukocytes and filled them with dexamethasone (DXM), an anti-inflammatory agent.
“We used ‘personalized’ DXM-loaded leukosomes to treat inflammation in mice,” Tasciotti said. “After administering the leukosomes, we observed their attachment to the surface of blood vessels surrounding the inflamed tissue, and they selectively delivered DXM to the affected cells.”
The treated mice showed definite signs of improvement, including resolution of the inflammation, a significant reduction in tissue thickness, and a reversal of the immune response that is commonly seen in inflammation.
The success of the team’s initial leukosome trial is encouraging, Tasciotti said, and suggests that membranes purified from any other cell types could also be used as biomimetic nanocarriers to treat other diseases.
“By combining cell biology with nanotechnology, we can create valuable medical tools that work within, and not around, the laws of nature,” he said.
Learn more: Nanoscale trojan horses treat inflammation
The Latest on: Treating inflammation
via Google News
The Latest on: Treating inflammation
- Immunotherapeutic antibody therapy to kill cancer has now progressed to patient testing on February 20, 2019 at 8:39 pm
One reason behind many unsuccessful cancer treatments is the cancers' ability to hijack the ... Macrophages have a large repertoire of functions in immune activation and resolving inflammation. In col... […]
- Native California medicinal plant may hold promise for treating Alzheimer's on February 20, 2019 at 3:50 pm
A discovery of a potent neuroprotective and anti-inflammatory chemical in a native California shrub may lead to a treatment for Alzheimer's disease based on a compound found in nature. The medicinal p... […]
- Unstable genomes promote inflammation on February 20, 2019 at 10:53 am
Anti-inflammatory treatments, such as ibuprofen or testosterone, protected the female embryos from death without restoring MCM function. Conversely, both female and male embryos died when the receptor ... […]
- Testosterone Helps Protect Embryos From Inflammation, Mouse Study Suggests on February 20, 2019 at 10:51 am
a safe anti-inflammatory treatment might prove to be beneficial,” Schimenti said. But, “we have no idea if anything similar is happening in people,” he added. Schimenti cautions the ... […]
- Inflammation and Autoimmune Diseases Class on February 20, 2019 at 8:07 am
and inflammatory foods (such as gluten and nightshades), etc. Health conditions can ramp up your feelings of stress, and treatments that take into account all of the factors that affect you give ... […]
- Abnormal cellular process implicated in gut inflammation and onset of inflammatory bowel disease on February 20, 2019 at 7:54 am
Under conditions of chronic, ongoing inflammation, the normal renewal of ... new targets or strategies on which new therapies to treat or prevent IBD can be based. […]
- Targeting Inflammation Through Cytokines to Treat Depressive Symptoms on February 20, 2019 at 5:55 am
Antidepressant efficacy emerged when patients showed a reduction in depression symptoms as a beneficial side effect of anti-TNF-alfa or anti-IL-6 therapy for autoimmune conditions. “Clinicians should ... […]
- Glenmark gets USFDA nod for generic skin inflammation treatment foam on February 19, 2019 at 5:11 pm
New Delhi, Feb 18 (PTI) Glenmark Pharmaceuticals Monday said it has received final approval from the US health regulator for its generic version of clobetasol propionate foam, a steroid used to treat ... […]
- New scan technique reveals brain inflammation associated with post-treatment Lyme disease syndrome on February 16, 2019 at 11:03 am
Editor’s Note: Most researchers and Lyme-literate doctors actually believe that “post-treatment Lyme disease syndrome” does not exist, and that the presence of ongoing symptoms following treatment is ... […]
- Rare Inflammatory Disease Treatment Market is Evolving with High Growth Rate of CAGR 5.89 % on February 13, 2019 at 10:51 am
Feb 13, 2019 (Heraldkeeper via COMTEX) -- New York, February 13, 2019: Global Rare Inflammatory Disease Treatment market is segregated on the basis of drug class as biologics and organic compounds. Ba... […]
via Bing News